← Leaderboards
Edward Hartsough
Thomas Jefferson University
$1,866,642
Attributed
$1,866,642
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $476.6K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,866,642 · 3
By mechanism
R01$946,823 · 1
R00$700,939 · 1
K99$218,880 · 1
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Philip B Wedegaertner$10,939,933
- Emad S. Alnemri$20,242,349
- Ha Linh Vu$207,489
- Michael Joseph Vido$192,753
- Clinita Randolph$134,580
Others in their field
Other Emerging Leaders on “Monitor”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Kimberly Smith · Ppd Development Lp$116,656,661
- Yunda Huang · Fred Hutchinson Cancer Center$71,488,059
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Martha Hering · Westat, Inc.$57,098,843
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
MonitorData SetKnock-DownMigrationResistanceMalignant NeoplasmsInnovationIn Vivo ModelLinkMelanoma CellNeoplasm MetastasisProteinsResponseMutantCoculture TechniquesGenesIn VitroIn VivoCell LineCellsApoptosisBiopsy SpecimenExtracellularBiopsy
Grant awards (7)
Exploiting oxidative stress response in uveal melanoma liver metastases$470,236
R01 · FY2025 · CA · contact PI
Exploiting oxidative stress response in uveal melanoma liver metastases$476,587
R01 · FY2024 · CA · contact PI
The role of CADM1 in malignant melanoma$249,000
R00 · FY2020 · CA · contact PI
The role of CADM1 in malignant melanoma$202,939
R00 · FY2019 · CA · contact PI
The role of CADM1 in malignant melanoma$249,000
R00 · FY2018 · CA · contact PI
The role of CADM1 in malignant melanoma$109,440
K99 · FY2018 · CA · contact PI
The role of CADM1 in malignant melanoma$109,440
K99 · FY2017 · CA · contact PI